SCHEMBL3852407

SCHEMBL3852407

Fc1ccc(-c2n[nH]cc2-c2ccc3ncnc(N4CCN(c5cccc(C(F)(F)F)c5)CC4)c3c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 12/20 0.49
CYP1A2 P05177 11/20 0.49
ALDH1A1 P00352 10/20 0.49
CYP2C19 P33261 9/20 0.49
TSHR P16473 7/20 0.49
HIF1A Q16665 7/20 0.49
MAPK1 P28482 6/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
USP2 O75604 4/20 0.49
CYP2D6 P10635 3/20 0.49
CLK4 Q9HAZ1 8/20 0.47
LMNA P02545 8/20 0.47
HSD17B10 Q99714 3/20 0.47
TP53 P04637 2/20 0.47
ALOX15 P16050 1/20 0.47
PHGDH O43175 1/20 0.46
HPGD P15428 4/20 0.46
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845114 0.89 CYP3A4 (0.52) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3852116 0.87 CYP3A4 (0.52) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3849819 0.83 ACHE (0.50) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3848419 0.82 CYP3A4 (0.63) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
Trifluoroacetic Acid SCHEMBL3852806 0.82 CYP3A4 (0.43) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3849265 0.81 CYP3A4 (0.56) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3851515 0.81 CYP1A2 (0.51) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3848383 0.80 CYP1A2 (0.48) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3848700 0.80 CYP3A4 (0.48) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR
SCHEMBL3846990 0.80 ACHE (0.54) CYP3A4CYP1A2ALDH1A1CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed